NDC 70377-095 – Liraglutide

Liraglutide 6 mg/mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC70377-095

Product details

Brand name
Liraglutide
Generic name
Liraglutide
Labeler
Biocon Pharma Inc.
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
ANDA · ANDA217063
Marketed since
March 27, 2026
Listing expires
December 31, 2027
Pharmacologic class
GLP-1 Receptor Agonist

Active ingredients

Uses, dosage, side effects and warnings for Liraglutide →

Package NDC codes (2)

Package NDCDescriptionSince
70377-095-523 SYRINGE, PLASTIC in 1 CARTON (70377-095-52) / 3 mL in 1 SYRINGE, PLASTICMar 27, 2026
70377-095-535 SYRINGE, PLASTIC in 1 CARTON (70377-095-53) / 3 mL in 1 SYRINGE, PLASTICMar 27, 2026

Other Liraglutide products